The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of the investigational drug alisertib in combination with abiraterone and prednisone (AP) for patients with metastatic castration-resistant prostate cancer (mCRPC) progressing on abiraterone.
 
Jianqing Lin
No Relationships to Disclose
 
Ashwin Reddy Sama
Honoraria - OncoPlex Diagnostics
Research Funding - Incyte (Inst)
Travel, Accommodations, Expenses - Celgene
 
Jean H. Hoffman-Censits
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Sanofi
 
Brooke Kennedy
No Relationships to Disclose
 
Deborah Kilpatrick
No Relationships to Disclose
 
Zhong Ye
No Relationships to Disclose
 
Hushan Yang
No Relationships to Disclose
 
Zhaomei Mu
No Relationships to Disclose
 
Benjamin E Leiby
No Relationships to Disclose
 
Nancy Lewis
No Relationships to Disclose
 
Massimo Cristofanilli
Honoraria - Agendia; Cynvenio Biosystems; Dompé Farmaceutici
Consulting or Advisory Role - Cynvenio Biosystems; Dompé Farmaceutici; Newomics
Speakers' Bureau - Agendia; NanoString Technologies
 
William Kevin Kelly
Consulting or Advisory Role - Sanofi
Research Funding - Novartis (Inst); Sanofi (Inst)
Other Relationship - Sanofi